Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, serves as a powerful HIV medication. It inhibits the multiplication of the human immunodeficiency virus (HIV) by preventing the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, allowing the virus to insert its genetic material into the host's DNA. Abaca

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor administered in the management of human immunodeficiency virus disease. Its therapeutic properties rely on the selective inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a pro-drug that experiences conversion to its active form, car

read more

Premier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for enterprises of all sizes. Top-rated global API manufacturer and supplier offers a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a unwavering commitment to quality, innovation, and c

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor employed in the management of human immunodeficiency virus infection. Its pharmacological properties involve the selective inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a metabolite that experiences transformation to its active

read more

India's Premier Nutraceutical API Supplier

India has firmly established itself as a global hub for dietary supplement ingredient manufacturing, particularly in the realm of Active Pharmaceutical Ingredients (APIs). Numerous domestic firms specialize in the specialized production of nutraceutical APIs, serving both the national market and exporting globally. These businesses boast advanced i

read more